相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
Expression of the stem cell marker CD133 in pancreas and pancreatic ductal adenocarcinomas
Heike Immervoll et al.
BMC CANCER (2008)
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L. M. Smith et al.
BRITISH JOURNAL OF CANCER (2008)
CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
S. Maeda et al.
BRITISH JOURNAL OF CANCER (2008)
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors
Norazizah Shafee et al.
CANCER RESEARCH (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
Jian Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
W. Song et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Expression of CD133-1 and CD133-2 in ovarian cancer
G. Ferrandina et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells
Scott Bidlingmaier et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Pluripotent human stem cell lines: what we can learn about cancer initiation
Tamra E. Werbowetski-Ogilvie et al.
TRENDS IN MOLECULAR MEDICINE (2008)
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S. Ma et al.
ONCOGENE (2008)
Exploring the role of cancer stem cells in radioresistance
Michael Baumann et al.
NATURE REVIEWS CANCER (2008)
Cancer stem cells as mediators of treatment resistance in brain tumors: Status and controversies
Per O. Sakariassen et al.
NEOPLASIA (2007)
Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence
Edward H. Lin et al.
CANCER (2007)
Tumor growth need not be driven by rare cancer stem cells
Priscilla N. Kelly et al.
SCIENCE (2007)
CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
Dagmar Beier et al.
CANCER RESEARCH (2007)
Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name?
Jiri Neuzil et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Increased expression of stem cell markers in malignant melanoma
Walter M. Klein et al.
MODERN PATHOLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases
Niven Mehra et al.
CLINICAL CANCER RESEARCH (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
Identification of bronchioalveolar stem cells in normal lung and lung cancer
CFB Kim et al.
CELL (2005)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
NY Frank et al.
CANCER RESEARCH (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)